昭衍新药

- 603127

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2025  2024  2023  2022  2021  2020  2019  2018  2017  2016 
昭衍新药(603127) 利润表
单位:万元
报表日期2025-12-312025-09-302025-06-302025-03-312024-12-31
一、营业总收入165,762.4398,496.1566,857.5228,733.72201,833.38
营业收入165,762.4398,496.1566,857.5228,733.72201,833.38
二、营业总成本166,321.46102,542.7966,739.4328,825.29176,374.83
营业成本131,431.2277,268.1450,793.5320,513.29144,456.02
营业税金及附加910.24617.89431.72135.21898.14
销售费用3,691.172,204.191,460.87607.932,788.11
管理费用28,226.1421,357.4913,450.527,178.4228,918.06
财务费用-6,680.20-5,291.34-3,741.81-1,912.34-9,977.32
研发费用8,742.896,386.434,344.612,302.799,291.83
资产减值损失----------
公允价值变动收益44,756.0316,919.7910,701.916,587.55-12,704.86
投资收益1,801.392,003.331,313.53123.593,601.15
其中:对联营企业和合营企业的投资收益--------1,547.13
汇兑收益----------
三、营业利润33,799.119,945.207,985.554,938.2610,434.73
加:营业外收入40.5338.7231.974.8422.35
减:营业外支出90.3121.395.564.7253.17
其中:非流动资产处置损失----------
四、利润总额33,749.339,962.548,011.964,938.3710,403.91
减:所得税费用3,965.071,891.931,918.72826.433,428.40
五、净利润29,784.258,070.606,093.244,111.956,975.51
归属于母公司所有者的净利润29,784.108,070.616,093.244,111.957,407.54
少数股东损益0.15-0.00-0.00-0.00-432.03
六、每股收益
基本每股收益(元/股)0.40000.11000.08000.05000.1000
稀释每股收益(元/股)0.40000.11000.08000.05000.1000
七、其他综合收益-1,928.78-648.02-233.41-76.69-5,104.11
八、综合收益总额27,855.487,422.585,859.834,035.251,871.40
归属于母公司所有者的综合收益总额27,855.337,422.585,859.834,035.262,303.43
归属于少数股东的综合收益总额0.15-0.00-0.00-0.00-432.03
下载全部历史数据到excel中 返回页顶